{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A survey among physicians to understand the management practices for Acid Peptic Disorders (STAMP)
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. What are the most common symptoms of Acid Peptic Disorders (APD) you encounter? (Please select more than one option if applicable) *

  2. How do you commonly diagnose APD? *
  3. Which of the following comorbidities have you commonly observed in patients with APD in your practice? (Select all that is applicable) *

  4. What are the most common overlapping conditions observed in your GERD patients? (Please tick all that is applicable) *

  5. In your practice, what is the prevalence of APD? *

  6. In your practice, what is the prevalence of GERD? *

  7. What is the prevalence of patients with Functional Dyspepsia (FD) in your practice? *

  8. What is the prevalence of patients with refractory cases of GERD in your practice? *

  9. What is the most common age group of patients you encounter with complaints of GERD/APD? *

  10. What are the goals of treatment for GERD? *

  11. For which of the following indications do you use PPIs? (Tick all that are applicable) *

  12. Do you consider lifestyle modifications an essential part of GERD management? *

  13. Which class of medication is commonly used by you as first-line therapy for GERD? *

  14. In your practice, which is the most commonly prescribed PPI? *

  15. Amongst the PPI, which is more efficacious in the treatment of APD as per your practice? *

  16. What is your drug of choice to manage GERD? (Select if more than one option is applicable) *

  17. How long do you usually prescribe a PPI in patients with GERD? *

  18. In patients with GERD, what is your choice of treatment pattern? *

  19. Do you use PPI along with H2RA? *

  20. Do you use PPI along with antacids? *

  21. Please choose your preferred combination for the above condition (Select if more than one option is applicable) *

  22. Do you use PPI along with Prokinetics in FD? *

  23. What are the criteria for selecting a PPI? (Tick all that are applicable) *

  24. In a patient with CKD/renal disease, what is your preferred PPI? *

  25. In a patient with cardiac conditions, what is your preferred PPI? *

  26. While prescribing an NSAID, what is your preferred PPI? *

  27. In patients with erosive esophagitis or strictures, what is your preferred dosing pattern for PPI? *

  28. Which is the PPI of choice for lower drug-drug interactions in patients taking multiple drugs in your practice *

  29. How frequently do you attempt to de-prescribe PPI therapy in your practice? *
    30. (e.g., Symptoms of nonerosive reflux disease with no sustained response to high-dose PPI therapy, functional dyspepsia with no sustained response to PPI therapy, steroid therapy in the absence of NSAID therapy, prevention of recurrent upper GI bleeding from causes other than: peptic ulcer disease, including gastric and duodenal erosions, erosive esophagitis)

  30. What is your preferred approach to de-prescribe PPI therapy? *

  31. What is the most common reason for prescribing PPIs as an adjuvant therapy? *

  32. How do you manage the refractory GERD cases? *

  33. What are the barriers to effective management of GERD/APD (Tick all that is applicable)? *

  34. Please share any new/emerging therapy for GERD/APD that is of interest to you. *
  35. What lifestyle advice do you find patients most resistant to follow, and how do you address this challenge? *
  36. Can you describe a recent case of APD that required deviation from standard treatment protocols? What influenced your decision-making? *
  37. Have you observed any patterns in treatment response among patients with different dietary or cultural backgrounds? *
  38. What gaps do you see in current guidelines or available therapies for APD? *
  39. How do you approach the management of APD in elderly patients or those with multiple comorbidities? *
  40. What role, if any, do you think gut-brain axis or psychosocial factors play in APD symptoms, and how do you integrate that into management?